Parallel Advisors’s GeneDx Holdings WGS Stock Holding History

Parallel Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$520	–	3964
2025 Q4	$520	Hold	4	–	–	﹤0.01%	3396
2025 Q3	$431	Buy	4 +3	+300%	+$327	﹤0.01%	3351
2025 Q2	$49	Buy	+1	New	+$79	﹤0.01%	3495
2025 Q1	–	Sell	-3	Closed	-$231	–	3684
2024 Q4	$231	Buy	+3	New	+$210	﹤0.01%	3355
2021 Q3	–	Sell	-102	Closed	-$47K	–	3286
2021 Q2	$47K	Buy	102 +45	+79%	+$19.3K	﹤0.01%	1277
2021 Q1	$28K	Buy	+57	New	+$29.6K	﹤0.01%	1450

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallel Advisors's WGS Position: Q1 2026 in Review

Parallel Advisors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 4 shares — an estimated $520 sold.

Parallel Advisors first reported a position in WGS in Q1 2021 and held it in 6 quarters. The position peaked at $47K in Q2 2021. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

Parallel Advisors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
Parallel Advisors sold 4 GeneDx Holdings shares in Q1 2026, an estimated $520.
Parallel Advisors first reported a position in GeneDx Holdings in Q1 2021 and held it in 6 quarters.
Parallel Advisors's GeneDx Holdings position peaked at $47K in Q2 2021.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.